Evidence map›Paper›PMID 36192797›Full record

ArticleBiotechnology for biofuels and bioproducts2022

Engineering Yarrowia lipolytica for the sustainable production of β-farnesene from waste oil feedstock.

Yinghang Liu, Jin Zhang, Qingbin Li, Zhaoxuan Wang, Zhiyong Cui, Tianyuan Su, Xuemei Lu, Qingsheng Qi, Jin Hou

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels and bioproducts, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. 10 years of CRISPR/CAS genomic engineering in Yarrowia lipolytica.Bioprocess and biosystems engineering · 2026
    Review
  5. Article
  6. Article
  7. EngineeringSynthetic and systems biotechnology · 2026
    Article
  8. Article
  9. EngineeringSynthetic and systems biotechnology · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Frontiers in bioengineering and biotechnology · 2025
    Review
  15. Developing polycistronic expression tool inSynthetic and systems biotechnology · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Systematic metabolic engineering ofFrontiers in bioengineering and biotechnology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yinghang Liu *State Key Laboratory of Microbial Technology, Shandong University, Binhai Road 72, Qingdao, 266237, China.
Jin Zhang *State Key Laboratory of Microbial Technology, Shandong University, Binhai Road 72, Qingdao, 266237, China.
Qingbin LiState Key Laboratory of Microbial Technology, Shandong University, Binhai Road 72, Qingdao, 266237, China.
Zhaoxuan WangState Key Laboratory of Microbial Technology, Shandong University, Binhai Road 72, Qingdao, 266237, China.
Zhiyong CuiState Key Laboratory of Microbial Technology, Shandong University, Binhai Road 72, Qingdao, 266237, China.
Tianyuan SuState Key Laboratory of Microbial Technology, Shandong University, Binhai Road 72, Qingdao, 266237, China.
Xuemei LuState Key Laboratory of Microbial Technology, Shandong University, Binhai Road 72, Qingdao, 266237, China.
Qingsheng QiState Key Laboratory of Microbial Technology, Shandong University, Binhai Road 72, Qingdao, 266237, China. qiqingsheng@sdu.edu.cn.
Jin HouState Key Laboratory of Microbial Technology, Shandong University, Binhai Road 72, Qingdao, 266237, China. houjin@sdu.edu.cn.
Shandong University · CNQingdao Binhai University · CNState Key Laboratory of Microbial Technology

Funding

Key R&D Program of Shandong Province 2020CXGC010602National Key Research and Development Program of China 2021YFC2100500National Natural Science Foundation of China 31970082National Natural Science Foundation of Shandong province ZR2020YQ18
6 · The paper itself

Abstract

backgroundβ-Farnesene is a sesquiterpene with versatile industrial applications. The production of β-farnesene from waste lipid feedstock is an attractive method for sustainable production and recycling waste oil. Yarrowia lipolytica is an unconventional oleaginous yeast, which can use lipid feedstock and has great potential to synthesize acetyl-CoA-derived chemicals.

resultsIn this study, we engineered Y. lipolytica to produce β-farnesene from lipid feedstock. To direct the flux of acetyl-CoA, which is generated from lipid β-oxidation, to β-farnesene synthesis, the mevalonate synthesis pathway was compartmentalized into peroxisomes. β-Farnesene production was then engineered by the protein engineering of β-farnesene synthase and pathway engineering. The regulation of lipid metabolism by enhancing β-oxidation and eliminating intracellular lipid synthesis was further performed to improve the β-farnesene synthesis. As a result, the final β-farnesene production with bio-engineering reached 35.2 g/L and 31.9 g/L using oleic acid and waste cooking oil, respectively, which are the highest β-farnesene titers reported in Y. lipolytica.

conclusionsThis study demonstrates that engineered Y. lipolytica could realize the sustainable production of value-added acetyl-CoA-derived chemicals from waste lipid feedstock.

Indexed as

Lipid metabolismWaste lipid feedstockYarrowia lipolyticaβ-Farneseneβ-Oxidation

Identifiers

PMID36192797
PMCPMC9528160
OpenAlexW4300089419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.